Suicide prevention brain marker study for depression treatment
Part of Mental health clinical trials.
This study looks for brain markers to better understand suicidal thoughts. It involves people who are already scheduled for ECT or ketamine treatment for depression and are willing to have an MRI scan and give blood samples.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have depression (major depressive disorder) or bipolar disorder, and you are currently in a depressive episode.
- You are having moderate to strong suicidal thoughts or behaviors.
- You are about to start a treatment course of ECT, IV ketamine, or esketamine nasal spray as part of your regular care.
- You do not have a neurological condition (like a brain injury) or any reason you cannot have an MRI, and you do not have alcohol dependence or withdrawal from other drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how ketamine affects the brain in people dealing with suicidal thoughts or an active suicide crisis. It uses questionnaires, consent testing, and brain imaging to look for biological changes that may relate to symptom improvement.
This study tests how ketamine affects brain chemicals linked to suicidal thoughts in people with depression. You will receive ketamine and have brain scans (PET and MRI) to see if it changes activity in opioid receptors.
This study looks at how certain brain “inhibitory” signals work in teenagers and young adults who have depression and either suicide thoughts or past suicide behavior. The goal is to better understand suicide risk and what might help reduce it, using brain and brainwave testing.
This research study tests different medication approaches for people with major depression who are having thoughts of suicide. The goal is to understand which treatments work best and why, so doctors can help patients more effectively.
This study tests a new type of brain stimulation called TMS (transcranial magnetic stimulation) for young people ages 15-25 who are having serious depression and suicidal thoughts. The goal is to see if this treatment can help reduce risk and improve mood.
This early-stage study tests how ketamine given once and then repeatedly may change brain signals and related biomarkers in people with major depression. If you’re eligible, the team will use brain imaging and assessments to see who responds and why.
Hear when a new Suicidal Thoughts and Behaviors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.